Lemonia Apocha1, Ifigenia Daskalaki1 , Magdalini Koroxenidou1 Anastasios Messis1 , Venetios Michelioudakis1 , Georgios Mouchtaridis1 Foteini Papadaki1 , Vasileios Stergiou1 , Emmanouil Stylianakis1 , Asteria Tsapadikou1 , Marios Lange2 , Nikolaos Ntelkis2 , Constantine Garagounis3 , Katerina Moutou4 , Kalliope K.Papadopoulou4
1iGEM Student Team Member
2iGEM Team Advisor
3iGEM Team Instructor
4iGEM Team PI
Amalthea is a complete, personalized, modular platform, which provides diagnosis, evaluation of the gut flora, and treatment of IBDs. A non-invasive encapsulated detection module, consisting of a genetically engineered bacteria-based system and an electronic system, will identify metabolite deficiencies directly correlated to IBDs, that may lead to malnutrition. Exploiting a bio-electronic interface to enable real-time monitoring on the patient’s smartphone. Based on this personalized data, a biosynthetic module will respond with selective production of the missing metabolites, thus eliminating that nutritional deficit and relieving the patient of the symptoms. Our product is designed according to healthcare experts and international standards, to ensure biosafety.